查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1501271

中东和北非地区婴儿奶粉市场－产业分析、规模、占有率、成长、趋势、预测（2031）- 依成分类型、依原料、依应用、依形式、依地区：（MENA）

MENA Infant Milk Formula Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (MENA)
出版日期: | 出版商: Fairfield Market Research | 英文 195 Pages | 商品交期: 2-5个工作天内

价格
简介目录

由于消费者对婴儿健康营养重要性的认识不断提高以及婴儿配方奶粉的日益普及，中东和北非地区婴儿配方奶粉的市场规模显着成长。婴儿配方奶粉目的是模拟人类母乳，作为自然母乳哺育的重要替代品，可确保婴儿获得正常生长和发育所需的营养和能量。

婴儿配方奶粉产业呈现强劲成长，反映出其在婴儿发育早期阶段的重要角色。该细分市场不断成长的市场占有率反映了对支持新生儿早期的高品质营养的需求不断成长。

婴儿配方奶粉产业持续扩张，主要针对从母乳哺育过渡到开始配方奶哺育的婴儿。此细分市场的成长反映出，随着婴幼儿的成长及其饮食需求的变化，人们对特种营养的偏好日益增加。

婴幼儿奶粉业务也稳定成长。此配方专为满足幼儿的营养需求而设计，在发育里程碑时提供均衡的必需营养素摄取。

线上零售业作为中东和北非地区婴儿配方奶粉的通路迅速发展。网路购物的便利性和可近性是其日益受到消费者欢迎的因素。该行业的成长率是所有分销管道中最高的，预计将继续保持上升趋势。

本报告调查了中东和北非地区的婴儿配方奶粉市场，并提供了市场概况，以及按成分、部署、解决方案、行业、地区和进入市场的竞争对手划分的趋势。

目录

第1章 执行摘要

第2章 市场概述

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • 新冠肺炎（COVID-19）影响分析
  • 乌克兰与俄罗斯衝突的影响
  • 经济概况
  • PESTLE分析

第3章 2018-2024年生产与贸易统计

第4章 价格分析，2018-2024

第5章 2018-2031年GCC婴儿配方奶粉市场前景

  • 2018-2031年GCC婴儿配方奶粉市场前景（依成分类型、价值（十亿美元）、量（MT））
  • 2018-2031年GCC婴儿配方奶粉市场前景（依原料、价值（十亿美元）、量（MT））
  • 2018-2031年GCC婴儿配方奶粉市场前景（依应用、价值（十亿美元）、量（MT））
  • 2018-2031年GCC婴儿配方奶粉市场前景（依形态、价值（十亿美元）、量（MT））
  • 2018-2031年GCC婴儿配方奶粉市场前景（依国家、价值（十亿美元）、量（MT））

第6章 2018-2031年北非婴儿配方奶粉市场前景

  • 2018-2031年北非婴儿配方奶粉市场前景（依成分类型、价值（十亿美元）、量（MT））
  • 2018-2031年北非婴儿配方奶粉市场前景（依原料、价值（十亿美元）、量（MT））
  • 2018-2031年北非婴儿配方奶粉市场展望（依应用、价值（十亿美元）、量（MT））
  • 2018-2031年北非婴儿配方奶粉市场前景（依形态、价值（十亿美元）、量（MT））

第7章 2018-2031年其他国家婴儿配方奶粉市场前景

  • 2018-2031年世界其他地区婴儿配方奶粉市场前景（依成分类型、价值（十亿美元）、销售（公吨））
  • 2018-2031年其他国家婴儿配方奶粉市场前景（依原料、价值（十亿美元）、产量（公吨））
  • 2018-2031年其他国家婴儿配方奶粉市展望（依应用、价值（十亿美元）、销售（公吨））
  • 2018-2031年其他国家婴儿配方奶粉市场前景（依形态、价值（十亿美元）、销售（公吨））
  • 2018-2031年其他国家婴儿配方奶粉市场前景（依国家、价值（十亿美元）、销售（公吨））

第八章 竞争态势

  • 2024年公司市占率分析
  • 竞争对手仪表板
  • 公司简介
    • Groupe Danone
    • Aspen Pharmacare Holdings Limited
    • Almarai
    • Nestle S.A.
    • Behdashtkar
    • Lacto Misr
    • Nutridar Company Plc
    • Ausnutria Hyproca B.V.
    • Saudi Centre Group
    • Abbott Laboratories
    • RIRI Baby Food CO.
    • 其他

第9章 附录

简介目录

The infant milk formula market in the MENA region is experiencing significant growth, driven by increasing consumer awareness about the importance of healthy nutrients for infants and the rising popularity of infant milk formula. Infant milk formula, designed to simulate human milk, serves as a crucial substitute for natural breastfeeding, ensuring that infants receive essential nutrients and energy for proper growth and development.

Market Segmentation and Growth

Starting Milk Formula The starting milk formula segment has shown robust growth, reflecting its critical role in the early stages of infant development. The segment's increasing market share highlights the demand for high-quality nutrition that supports newborns during their initial months.

Follow-On Milk Formula The follow-on milk formula segment continues to expand, catering to infants transitioning from breastfeeding or starting milk formula. This segment's growth is indicative of the increasing preference for specialized nutrition as infants grow and their dietary needs evolve.

Toddlers Milk Formula The toddlers milk formula segment is also experiencing steady growth. This formula is specifically designed to meet the nutritional needs of toddlers, ensuring they receive balanced nutrients essential for their developmental milestones.

Distribution Channels and Market Dynamics

Online Retail The online retail segment is emerging as a rapidly growing distribution channel for infant milk formula in the MENA region. The convenience and accessibility of online shopping have contributed to its rising popularity among consumers. This segment is expected to continue its upward trajectory, registering the highest growth rate among all distribution channels.

Supermarkets Supermarkets remain a significant distribution channel for infant milk formula, trusted by consumers for their wide range of products and convenient shopping experience. The supermarkets segment continues to grow, reflecting the strong consumer trust and preference for purchasing infant nutrition products from well-established retail outlets.

Chemists/Pharmacies/Drugstores Chemists, pharmacies, and drugstores are perceived as trusted sources for infant milk formula by consumers in the MENA region. This segment remains dominant, with a substantial share of the market, driven by the credibility and assurance these outlets provide to parents seeking reliable infant nutrition solutions.

Specialty Outlets Specialty outlets, including dedicated baby stores, offer a targeted approach to distributing infant milk formula. While smaller in market share compared to other channels, these outlets provide specialized advice and products, catering to parents looking for tailored nutrition solutions for their infants.

Other Distribution Channels Other distribution channels, including various local and independent stores, contribute to the overall market landscape. These channels provide additional options for consumers, supporting the widespread availability and accessibility of infant milk formula across the region.

Key Market Drivers

Rising Number of Working Women The increasing number of working women in the MENA region is a significant factor driving the growth of the infant milk formula market. As more women enter the workforce, the demand for convenient and reliable nutrition solutions for infants rises, boosting the market for infant milk formula.

Rapid Economic Development Rapid economic development in the MENA region has led to increased disposable incomes and improved living standards. This economic growth has positively impacted consumer spending on premium nutrition products, including infant milk formula, further propelling market growth.

Consumer Awareness Growing consumer awareness regarding the importance of healthy nutrition for infants is fueling the demand for infant milk formula. Parents are becoming more informed about the nutritional needs of their children and are increasingly opting for high-quality formula products that ensure proper growth and development.

Competitive Analysis

  • Behdashtkar, Lacto Misr.
  • Nutridar Company Plc.
  • Ausnutria Hyproca B.V.
  • Saudi Centre Group.
  • Abbott Laboratories.
  • RIRI Baby Food Co.
  • Groupe Danone.
  • Aspen Pharmacare Holdings Limited.
  • Almarai, Nestle S.A.
  • Other.

The MENA infant milk market is segmented as follows:

By product type

  • Starting milk formula
  • Follow-on milk formula
  • Toddlers milk formula

By distribution channel

  • Specialty store
  • Supermarkets
  • Online retail
  • Chemist/pharmacies/drugstore
  • Others

By region

  • GCC
    • Bahrain
    • Kuwait
    • Oman
    • Qatar
    • Kingdom of Saudi Arabia (KSA)
    • United Arab Emirates (UAE)
  • North Africa
    • Algeria
    • Egypt
    • Morocco
    • Tunisia
  • Rest of Middle East
    • Iraq
    • Jordan
    • Lebanon
    • Yemen

Table of Contents

1. Executive Summary

  • 1.1. MENA Infant Milk Formula Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2024

  • 3.1. MENA Infant Milk Formula Market Production Output, by Region, Value (US$ Bn) and Volume (MT), 2018 - 2024
    • 3.1.1. GCC
    • 3.1.2. North Africa
    • 3.1.3. Rest of Middle East and Africa

4. Price Analysis, 2018 - 2024

  • 4.1. Average Price Analysis, by Form, US$ Per MT, 2018 - 2024
  • 4.2. Prominent Factor Affecting MENA Infant Milk Formula Prices
  • 4.3. Average Price Analysis, by Region, US$ Per MT

5. GCC Infant Milk Formula Market Outlook, 2018 - 2031

  • 5.1. GCC Infant Milk Formula Market Outlook, by Ingredient Type, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Fats & Oils
      • 5.1.1.2. Minerals
      • 5.1.1.3. Proteins
      • 5.1.1.4. Vitamins
      • 5.1.1.5. Carbohydrates
      • 5.1.1.6. Prebiotics
      • 5.1.1.7. Others (Probiotics, Nucleotides, and Emulsifiers)
  • 5.2. GCC Infant Milk Formula Market Outlook, by Source, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Soy
      • 5.2.1.2. Protein hydrolysates
      • 5.2.1.3. Cow Milk
      • 5.2.1.4. Others (Goat milk and camel milk)
  • 5.3. GCC Infant Milk Formula Market Outlook, by Application, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. 0 to 6-month-old infants
      • 5.3.1.2. 6 to 12-month-old infants
      • 5.3.1.3. Infants over 12 months
      • 5.3.1.4. Specialty Formula
  • 5.4. GCC Infant Milk Formula Market Outlook, by Form, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Powder
      • 5.4.1.2. Liquid & semi-liquid
  • 5.5. GCC Infant Milk Formula Market Outlook, by Country, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Kuwait
      • 5.5.1.2. Oman
      • 5.5.1.3. Qatar
      • 5.5.1.4. Bahrain
      • 5.5.1.5. Saudi Arabia
    • 5.5.2. Key Highlights
      • 5.5.2.1. Kuwait Infant Milk Formula Market by Ingredient Type, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.2. Kuwait Infant Milk Formula Market by Source, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.3. Kuwait Infant Milk Formula Market by Application, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.4. Kuwait Infant Milk Formula Market by Form, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.5. Oman Infant Milk Formula Market by Ingredient Type, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.6. Oman Infant Milk Formula Market by Source, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.7. Oman Infant Milk Formula Market by Application, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.8. Oman Infant Milk Formula Market by Form, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.9. Qatar Infant Milk Formula Market by Ingredient Type, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.10. Qatar Infant Milk Formula Market by Source, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.11. Qatar Infant Milk Formula Market by Application, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.12. Qatar Infant Milk Formula Market by Form, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.13. Bahrain Infant Milk Formula Market by Ingredient Type, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.14. Bahrain Infant Milk Formula Market by Source, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.15. Bahrain Infant Milk Formula Market by Application, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.16. Bahrain Infant Milk Formula Market by Form, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 5.5.3. BPS Analysis/Market Attractiveness Analysis

6. North Africa Infant Milk Formula Market Outlook, 2018 - 2031

  • 6.1. North Africa Infant Milk Formula Market Outlook, by Ingredient Type, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Fats & Oils
      • 6.1.1.2. Minerals
      • 6.1.1.3. Proteins
      • 6.1.1.4. Vitamins
      • 6.1.1.5. Carbohydrates
      • 6.1.1.6. Prebiotics
      • 6.1.1.7. Others (Probiotics, Nucleotides, and Emulsifiers)
  • 6.2. North Africa Infant Milk Formula Market Outlook, by Source, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Soy
      • 6.2.1.2. Protein hydrolysates
      • 6.2.1.3. Cow Milk
      • 6.2.1.4. Others (Goat milk and camel milk)
  • 6.3. North Africa Infant Milk Formula Market Outlook, by Application, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. 0 to 6-month-old infants
      • 6.3.1.2. 6 to 12-month-old infants
      • 6.3.1.3. Infants over 12 months
      • 6.3.1.4. Specialty Formula
  • 6.4. North Africa Infant Milk Formula Market Outlook, by Form, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Powder
      • 6.4.1.2. Liquid & semi-liquid
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Rest of Middle East & Africa Infant Milk Formula Market Outlook, 2018 - 2031

  • 7.1. Rest of Middle East & Africa Infant Milk Formula Market Outlook, by Ingredient Type, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Fats & Oils
      • 7.1.1.2. Minerals
      • 7.1.1.3. Proteins
      • 7.1.1.4. Vitamins
      • 7.1.1.5. Carbohydrates
      • 7.1.1.6. Prebiotics
      • 7.1.1.7. Others (Probiotics, Nucleotides, and Emulsifiers)
  • 7.2. Rest of Middle East & Africa Infant Milk Formula Market Outlook, by Source, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Soy
      • 7.2.1.2. Protein hydrolysates
      • 7.2.1.3. Cow Milk
      • 7.2.1.4. Others (Goat milk and camel milk)
  • 7.3. Rest of Middle East & Africa Infant Milk Formula Market Outlook, by Application, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. 0 to 6-month-old infants
      • 7.3.1.2. 6 to 12-month-old infants
      • 7.3.1.3. Infants over 12 months
      • 7.3.1.4. Specialty Formula
  • 7.4. Rest of Middle East & Africa Infant Milk Formula Market Outlook, by Form, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Powder
      • 7.4.1.2. Liquid & semi-liquid
  • 7.5. Rest of Middle East & Africa Infant Milk Formula Market Outlook, by Country, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Jordan Infant Milk Formula Market by Ingredient Type, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.2. Jordan Infant Milk Formula Market by Source, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.3. Jordan Infant Milk Formula Market by Application, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.4. Jordan Infant Milk Formula Market by Form, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.5. Iraq Infant Milk Formula Market by Ingredient Type, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.6. Iraq Infant Milk Formula Market by Source, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.7. Iraq Infant Milk Formula Market by Application, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.8. Iraq Infant Milk Formula Market by Form, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.9. Lebanon Infant Milk Formula Market by Ingredient Type, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.10. Lebanon Infant Milk Formula Market by Source, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.11. Lebanon Infant Milk Formula Market by Application, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.12. Lebanon Infant Milk Formula Market by Form, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.13. Yemen Infant Milk Formula Market by Ingredient Type, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.14. Yemen Infant Milk Formula Market by Source, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.15. Yemen Infant Milk Formula Market by Application, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.16. Yemen Infant Milk Formula Market by Form, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Competitive Landscape

  • 8.1. Company Market Share Analysis, 2024
  • 8.2. Competitive Dashboard
  • 8.3. Company Profiles
    • 8.3.1. Groupe Danone
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Ingredient Type Portfolio
      • 8.3.1.3. Financial Overview
      • 8.3.1.4. Business Strategies and Development
    • 8.3.2. Aspen Pharmacare Holdings Limited
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Ingredient Type Portfolio
      • 8.3.2.3. Financial Overview
      • 8.3.2.4. Business Strategies and Development
    • 8.3.3. Almarai
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Ingredient Type Portfolio
      • 8.3.3.3. Financial Overview
      • 8.3.3.4. Business Strategies and Development
    • 8.3.4. Nestle S.A.
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Ingredient Type Portfolio
      • 8.3.4.3. Financial Overview
      • 8.3.4.4. Business Strategies and Development
    • 8.3.5. Behdashtkar
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Ingredient Type Portfolio
      • 8.3.5.3. Financial Overview
      • 8.3.5.4. Business Strategies and Development
    • 8.3.6. Lacto Misr
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Ingredient Type Portfolio
      • 8.3.6.3. Financial Overview
      • 8.3.6.4. Business Strategies and Development
    • 8.3.7. Nutridar Company Plc
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Ingredient Type Portfolio
      • 8.3.7.3. Financial Overview
      • 8.3.7.4. Business Strategies and Development
    • 8.3.8. Ausnutria Hyproca B.V.
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Ingredient Type Portfolio
      • 8.3.8.3. Financial Overview
      • 8.3.8.4. Business Strategies and Development
    • 8.3.9. Saudi Centre Group
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Ingredient Type Portfolio
      • 8.3.9.3. Financial Overview
      • 8.3.9.4. Business Strategies and Development
    • 8.3.10. Abbott Laboratories
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Ingredient Type Portfolio
      • 8.3.10.3. Financial Overview
      • 8.3.10.4. Business Strategies and Development
    • 8.3.11. RIRI Baby Food CO.
      • 8.3.11.1. Company Overview
      • 8.3.11.2. Ingredient Type Portfolio
      • 8.3.11.3. Financial Overview
      • 8.3.11.4. Business Strategies and Development
    • 8.3.12. Others
      • 8.3.12.1. Company Overview
      • 8.3.12.2. Ingredient Type Portfolio
      • 8.3.12.3. Financial Overview
      • 8.3.12.4. Business Strategies and Development

9. Appendix

  • 9.1. Research Methodology
  • 9.2. Report Assumptions
  • 9.3. Acronyms and Abbreviations